NCT01649817View on ClinicalTrials.gov

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

CompletedOBSERVATIONAL
Enrollment

183

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Rheumatoid Arthritis
Trial Locations (24)

11473

Athens

11521

Athens

12934

Peristeri

15121

Peuki

15342

Agía Paraskeví

16452

Argiroupoli

17343

Agios Dimitrios

19200

Eleusina

20100

Corinth

38221

Volos

54621

Thessaloniki

54622

Thessaloniki

54623

Thessaloniki

54624

Thessaloniki

62122

Serres

71307

Herakleio

73134

Chania

74100

Rethymno

155 62

Athens

Unknown

Athens

Chalandri

Kifissia

Thessaloniki

455 00

Ioannina

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01649817 - A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II) | Biotech Hunter | Biotech Hunter